CCL Industries completed the acquisition of Faubel for $186m.

CCL Industries, a security and packaging solutions provider, completed the acquisition of Faubel, a pharmaceutical company, for $186m. "Clinical trials labeling has long been an important component of our North American Healthcare business. This acquisition adds organizational and operational capacity in Europe to build a global presence in the space. We have known and admired Faubel for more than 15 years and are very pleased to welcome their outstanding team to our Company. It will become an integral part of the global Healthcare & Specialty business led by Lee Pretsell, Group Vice President, who reports to Guenther Birkner, President - Healthcare & Specialty, Food & Beverage and Innovia," Geoffrey T. Martin, CCL Industries President & CEO.